MA51151A - Inhibiteurs d'endo-exonucléase mono- et di-amidine et procédés d'inhibition de l'activité endo-exonucléase - Google Patents

Inhibiteurs d'endo-exonucléase mono- et di-amidine et procédés d'inhibition de l'activité endo-exonucléase

Info

Publication number
MA51151A
MA51151A MA051151A MA51151A MA51151A MA 51151 A MA51151 A MA 51151A MA 051151 A MA051151 A MA 051151A MA 51151 A MA51151 A MA 51151A MA 51151 A MA51151 A MA 51151A
Authority
MA
Morocco
Prior art keywords
endo
exonuclease
amidine
mono
methods
Prior art date
Application number
MA051151A
Other languages
English (en)
Inventor
Terry Chow
Original Assignee
Montdorex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montdorex Inc filed Critical Montdorex Inc
Publication of MA51151A publication Critical patent/MA51151A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
MA051151A 2017-11-16 2018-11-08 Inhibiteurs d'endo-exonucléase mono- et di-amidine et procédés d'inhibition de l'activité endo-exonucléase MA51151A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762587118P 2017-11-16 2017-11-16

Publications (1)

Publication Number Publication Date
MA51151A true MA51151A (fr) 2020-10-21

Family

ID=66538346

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051151A MA51151A (fr) 2017-11-16 2018-11-08 Inhibiteurs d'endo-exonucléase mono- et di-amidine et procédés d'inhibition de l'activité endo-exonucléase

Country Status (9)

Country Link
US (2) US11103468B2 (fr)
EP (1) EP3724161A4 (fr)
JP (2) JP7153734B2 (fr)
CN (1) CN111448181B (fr)
AU (1) AU2018367939B2 (fr)
CA (2) CA3075664C (fr)
IL (1) IL274340B2 (fr)
MA (1) MA51151A (fr)
WO (1) WO2019095046A1 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU164584B (fr) * 1971-11-19 1974-03-28
JPS60130561A (ja) 1983-12-16 1985-07-12 Torii Yakuhin Kk アミジン誘導体およびそれを含む強心剤
US5324830A (en) 1991-03-26 1994-06-28 United States Of America Chimeric protein that has a human RHo Motif and deoxyribonuclease activity
US5489524A (en) 1991-03-26 1996-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric protein that has a human Rho motif and deoxyribonuclease activity
CA2388674C (fr) * 1999-11-16 2005-01-25 Oncozyme Pharma Inc Inhibiteurs de l'activite des endo-exonucleases destines au traitement du cancer
US7115665B1 (en) 2000-11-16 2006-10-03 Onocozyme Pharma, Inc. Inhibitors of endo-exonuclease activity for treating cancer
EP1715857A1 (fr) 2004-01-23 2006-11-02 Neurochem (International) Limited Derives d'amidine pour le traitement de l'amylose
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CN101481332B (zh) 2009-02-26 2012-08-29 南京华狮化工有限公司 一种烷氧基芳脒化合物的合成方法
JP6370801B2 (ja) * 2012-12-21 2018-08-08 ベルリクス・ファーマ・インコーポレイテッド 肝疾患または肝障害の治療のための使用および方法
JP6507398B2 (ja) 2015-06-03 2019-05-08 日本曹達株式会社 グアニジン化合物および殺菌剤
CN106946790B (zh) * 2017-04-26 2019-08-06 华侨大学 一种1,2-取代苯并咪唑类衍生物的制备方法

Also Published As

Publication number Publication date
CN111448181B (zh) 2023-05-19
JP2022105018A (ja) 2022-07-12
CA3075664A1 (fr) 2019-05-23
AU2018367939A1 (en) 2020-06-18
US20200375924A1 (en) 2020-12-03
CA3086099C (fr) 2023-05-09
IL274340A (en) 2020-06-30
EP3724161A4 (fr) 2021-09-08
IL274340B2 (en) 2023-05-01
EP3724161A1 (fr) 2020-10-21
JP7153734B2 (ja) 2022-10-14
US11103468B2 (en) 2021-08-31
JP7395642B2 (ja) 2023-12-11
AU2018367939B2 (en) 2023-07-13
JP2021503016A (ja) 2021-02-04
CA3086099A1 (fr) 2019-05-23
CA3075664C (fr) 2020-12-29
WO2019095046A1 (fr) 2019-05-23
IL274340B1 (en) 2023-01-01
US20210338607A1 (en) 2021-11-04
CN111448181A (zh) 2020-07-24

Similar Documents

Publication Publication Date Title
MA42269A (fr) Compositions et procédés d'inhibition de l'activité de l'arginase
MA50636A (fr) Compositions et procédés pour inhiber l'activité d'arginase
IL267532B (en) Preparations and methods for inhibiting arginase activity
MA44990A (fr) Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-l1
MA45937A (fr) Inhibiteurs d'amino pyrimidine ssao
MA44991A (fr) Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-1
IL267090A (en) Amine-disubstituted heterocyclic compounds as ehmt2 inhibitors and methods of using them
MA51616A (fr) Inhibiteurs d'adn-pk
MA51066A (fr) Inhibiteurs d'intégrine
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
IL276813A (en) Arginase inhibitors
MA53239A (fr) Procédés d'administration de certains inhibiteurs de vmat2
MA45047A (fr) Procédés d'utilisation d'inhibiteurs de fasn
IL280051A (en) EP4 inhibitors and their synthesis
MA49006A (fr) Inhibiteurs d'ip6k
MA50912A (fr) Inhibiteurs d'acss2 et leurs procédés d'utilisation
SG11202008925VA (en) Inhibitors of micro-rna 22
MA50906A (fr) Inhibiteurs d'immunoprotéasome
IL286485A (en) pi4-kinase inhibitors and methods of using them
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
MA51151A (fr) Inhibiteurs d'endo-exonucléase mono- et di-amidine et procédés d'inhibition de l'activité endo-exonucléase
MA53009A (fr) Agents inhibiteurs d'ask1
MA55203A (fr) Inhibiteurs d'azétidinyl 0-glyc0pr0téin-2-acétamid0-2-désoxy-3-d-gluc0pyran0sidase
ZA202005459B (en) Methods of use and pharmaceutical compositions of a selective syk inhibitor
SG11202111834WA (en) Systems and methods for deterring guest evacuations